Abstract
The present study investigates whether transplantation of NSCs treated with T3 alone (T3/NSCs), or in conjunction with GDNF gene (GDNF-T3/NSCs), provides a better therapeutic effect than NSCs for chronic EAE. EAE rats were, respectively, injected with NSCs, T3/NSCs, GDNF-T3/NSCs, and saline at 10 days and sacrificed at 60 days after EAE immunization. The three cell grafted groups showed a significant reduction in clinical scores, inflammatory infiltration, and demyelination compared with the saline-injected group, and among the cell grafted groups, the reduction in GDNF-T3/NSCs group was the most notable, followed by T3/NSCs group. Grafted T3/NSCs and GDNF-T3/NSCs acquired more MAP2, GalC, and less GFAP in brain compared with grafted NSCs, and grafted GDNF-T3/NSCs acquired most MAP2 and least GalC among the cell grafted groups. Furthermore, T3/NSCs and GDNF-T3/NSCs grafting increased the expression of mRNA for PDGFαR, GalC, and MBP in lesion areas of brain compared with NSCs grafting, and the expression of mRNA for GalC and MBP in GDNF-T3/NSCs group was higher than that in T3/NSCs group. In conclusion, T3/NSCs grafting, especially GDNF-T3/NSCs grafting, provides a better neuroprotective effect for EAE than NSCs transplantation.
References
Jan 26, 1995·Nature·K D BeckF Hefti
Nov 11, 1994·Science·C E HendersonA Rosenthal
May 21, 1993·Science·L F LinF Collins
Feb 5, 2000·Nature·M S RamerS B McMahon
Oct 4, 2000·The Journal of Experimental Medicine·L IziksonA D Luster
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Laura CalzaLuciana Giardino
Apr 18, 2003·Nature·Stefano PluchinoGianvito Martino
Nov 11, 2003·The Journal of Comparative Neurology·Armin Blesch, Mark H Tuszynski
Nov 10, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mercedes FernandezLaura Calzà
Jul 15, 2005·Nature·Stefano PluchinoGianvito Martino
Feb 14, 2006·Experimental Neurology·Ofira EinsteinTamir Ben-Hur
Jun 24, 2008·Experimental Neurology·P G FrancoJ M Pasquini
Sep 6, 2008·PloS One·Michal AharonowizTamir Ben-Hur
Jan 9, 2009·Cellular and Molecular Neurobiology·Shinya ObayashiJun-ichi Satoh
Feb 24, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Roberta BrambillaJohn R Bethea
Jun 13, 2009·Brain Research·B ChenQ L Yuan
Jun 23, 2009·PloS One·Stefano PluchinoGianvito Martino
Sep 2, 2009·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·M FernándezL Calzà
Nov 4, 2009·Journal of Neuroscience Research·Mikhal E CohenTamir Ben-Hur
Dec 17, 2009·Acta Neuropathologica·Michael V Sofroniew, Harry V Vinters
May 21, 2010·Journal of Neuroinflammation·Henrik WilmsRalph Lucius
Aug 5, 2010·Clinical and Experimental Immunology·J M FletcherK H G Mills
Feb 25, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yan ZhouAkio Suzumura
Jun 18, 2011·Neurobiology of Disease·Francesco GirolamoDaniela Virgintino
Oct 20, 2011·Neuropathology and Applied Neurobiology·M L Dell'AcquaL Calzà
Apr 5, 2012·Molecular and Cellular Neurosciences·Jason C DugasBen A Barres
Apr 25, 2012·Acta Neuropathologica·Jingxian YangGuang-Xian Zhang
Nov 14, 2012·Bioengineered·Robert P MurphyMark Pickering
Jan 24, 2013·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Sofia GradeJoão O Malva
Oct 8, 2013·Lancet·Claire M RiceNeil J Scolding
Dec 21, 2013·Glia·Roberta BrambillaJohn R Bethea
Jan 21, 2014·Journal of Pharmacological Sciences·Zhong GaoSafeng Zou
Sep 14, 2014·Nature Medicine·Lior MayoFrancisco J Quintana
Oct 8, 2014·ASN Neuro·Carlos E PedrazaMichael Webb
Dec 3, 2014·Proceedings of the National Academy of Sciences of the United States of America·Spencer M MooreSeema Kaushalya Tiwari-Woodruff